Last reviewed · How we verify
TJ202 and Dexamethasone
TJ202 and Dexamethasone is a Small molecule drug developed by TJ Biopharma Co., Ltd.. It is currently in Phase 2 development.
At a glance
| Generic name | TJ202 and Dexamethasone |
|---|---|
| Sponsor | TJ Biopharma Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- TJ202 Combined With Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma (PHASE2)
- TJ202, Lenalidomide and Dexamethasone vs. Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- TJ202 and Dexamethasone CI brief — competitive landscape report
- TJ202 and Dexamethasone updates RSS · CI watch RSS
- TJ Biopharma Co., Ltd. portfolio CI
Frequently asked questions about TJ202 and Dexamethasone
What is TJ202 and Dexamethasone?
TJ202 and Dexamethasone is a Small molecule drug developed by TJ Biopharma Co., Ltd..
Who makes TJ202 and Dexamethasone?
TJ202 and Dexamethasone is developed by TJ Biopharma Co., Ltd. (see full TJ Biopharma Co., Ltd. pipeline at /company/tj-biopharma-co-ltd).
What development phase is TJ202 and Dexamethasone in?
TJ202 and Dexamethasone is in Phase 2.
Related
- Manufacturer: TJ Biopharma Co., Ltd. — full pipeline
- Compare: TJ202 and Dexamethasone vs similar drugs
- Pricing: TJ202 and Dexamethasone cost, discount & access